Kexing Biopharm Co., Ltd. (SHA:688136)
30.20
-0.32 (-1.05%)
At close: Feb 13, 2026
59.79% (1Y)
| Market Cap | 5.98B +76.9% |
| Revenue (ttm) | 1.52B +14.2% |
| Net Income | 125.57M |
| EPS | 0.62 |
| Shares Out | 198.11M |
| PE Ratio | 48.73 |
| Forward PE | 48.32 |
| Dividend | 0.08 (0.26%) |
| Ex-Dividend Date | n/a |
| Volume | 1,920,810 |
| Average Volume | 3,099,877 |
| Open | 30.52 |
| Previous Close | 30.52 |
| Day's Range | 30.20 - 30.84 |
| 52-Week Range | 18.53 - 63.99 |
| Beta | 0.80 |
| RSI | 35.73 |
| Earnings Date | Mar 28, 2026 |